 | • レポートコード：TPM-DJ090 • 出版社/出版日：Transparency Market Research / 2019年3月25日 • レポート形態：英文、PDF、190ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、心臓バイオマーカー診断キットの世界市場について調べ、心臓バイオマーカー診断キットの市場規模、市場動向、市場シェア、市場環境、市場予測、関連企業情報などをまとめました。 |
Global Cardiac Biomarker Diagnostic Kits Market: Overview
This report on the global cardiac biomarker diagnostic kits market comprises an elaborate executive summary, including a market snapshot that provides information about various segments of the market. The report also provides information and data analysis of the global market with respect to its segments based on disease indication, product, testing, and end-user. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises a competitive matrix and company profiles with business overview to project the competitive landscape of the market. It also provides market attractiveness analysis in terms of region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario prevailing in the global cardiac biomarker diagnostic kits market.
Global Cardiac Biomarker Diagnostic Kits Market: Key Segments
Based on disease indication, the global cardiac biomarker diagnostic kits market has been segmented into angina pectoris, myocardial infraction, cardiac heart failure, and others. In terms of testing, the market has been classified into laboratory testing and point of care testing. In terms of product, the market has been classified into troponin test kits, CK-MB test kits, myoglobin test kits, BNP Test Kit, C-reactive Protein (hsCRP), and other biomarkers. Based on end-user, the market has been categorized into hospitals, clinics, diagnostics centers, and others. The global cardiac biomarker diagnostic kits market has been analyzed based on increasing regulatory scrutiny, technology trends, expenditure on emerging technologies and presence of key players in the region. Market size and forecast for each of these segments have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.
Global Cardiac Biomarker Diagnostic Kits Market: Regional Outlook
In terms of region, the global cardiac biomarker diagnostic kits market has been categorized into five major regions and key countries in these regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC, South Africa, and Rest of Middle East & Africa). Market size and forecast for each of these regions and their key countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period 2018-2026, considering 2017 as the base year.
Companies Mentioned in the Report
The report profiles major players operating in the global Cardiac Biomarker Diagnostic Kits market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in this report include Abbott Laboratories, Hoffmann-La Roche AG, Bio-Rad Laboratories, Danaher Corporation, Seimens Healthineers, Thermofisher Scientific, bioMérieux, Randox Laboratories Ltd., and Ortho Clinical Diagnostics.
The global cardiac biomarker diagnostic kits market has been segmented as follows:
Global Cardiac Biomarker Diagnostic Kits Market, by Disease Indication
Angina pectoris
Myocardial Infraction (MI)
Cardiac Heart Failure
Others
Global Cardiac Biomarker Diagnostic Kits Market, by Product
Troponin Test Kits
CK-MB Test Kits
Myoglobin Test Kits
BNP Test Kit
C-reactive Protein (hsCRP)
Other Biomarkers (galectin-3, H-FABP, myeloperoxidase, ischemia-modified albumin, and homocysteine)
Global Cardiac Biomarker Diagnostic Kits Market, Testing
Laboratory Testing
Pont-of-care Testing
Global Cardiac Biomarker Diagnostic Kits Market, by End-user
Hospitals
Clinics
Diagnostic Centers
Others
Global Cardiac Biomarker Diagnostic Kits Market, by Region
North America
U.S
Canada
Europe
Germany
U.K
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Australia & New Zealand
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cardiac Biomarker Diagnostic Kits Market
4. Market Overview
4.1. Introduction
4.1.1. Products Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Mergers & Acquisitions
5.3. Reimbursement Scenario
5.4. Cardiac Diseases Prevalence Rate Globally with Key Countries
5.5. Top 3 players operating in the market space
6. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
6.3.1. Troponin Test Kits
6.3.2. CK-MB Test Kits
6.3.3. Myoglobin Test Kits
6.3.4. BNP Test Kit
6.3.5. C-reactive Protein (hsCRP)
6.3.6. Others
6.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Product
7. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Testing
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
7.3.1. Laboratory Testing
7.3.2. Pont-of-care Testing
7.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Testing
8. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Disease Indication
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
8.3.1. AngiStent Type Pectoris
8.3.2. Myocardial Infraction
8.3.3. Cardiac Heart Failure
8.3.4. Other
8.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Disease Indication
9. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Diagnostic Laboratory
9.3.4. Others
9.4. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by End-user
10. Global Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Cardiac Biomarker Diagnostic Kits Market Attractiveness, by Region
11. North America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
11.2.1. Troponin Test Kits
11.2.2. CK-MB Test Kits
11.2.3. Myoglobin Test Kits
11.2.4. BNP Test Kit
11.2.5. C-reactive Protein (hsCRP)
11.2.6. Others
11.3. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
11.3.1. Laboratory Testing
11.3.2. Pont-of-care Testing
11.4. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
11.4.1. AngiStent Type Pectoris
11.4.2. Myocardial Infraction
11.4.3. Cardiac Heart Failure
11.4.4. Other
11.5. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
11.5.1. Hospitals
11.5.2. Clinics
11.5.3. Diagnostic Laboratory
11.5.4. Others
11.6. North America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country, 2016–2026
11.6.1. U.S.
11.6.2. Canada
11.7. North America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Testing
11.7.3. By Disease Indication
11.7.4. By End-user
11.7.5. By Country
12. Europe Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
12.2.1. Troponin Test Kits
12.2.2. CK-MB Test Kits
12.2.3. Myoglobin Test Kits
12.2.4. BNP Test Kit
12.2.5. C-reactive Protein (hsCRP)
12.2.6. Others
12.3. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
12.3.1. Laboratory Testing
12.3.2. Pont-of-care Testing
12.4. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
12.4.1. AngiStent Type Pectoris
12.4.2. Myocardial Infraction
12.4.3. Cardiac Heart Failure
12.4.4. Other
12.5. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
12.5.1. Hospitals
12.5.2. Clinics
12.5.3. Diagnostic Laboratory
12.5.4. Others
12.6. Europe Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Testing
12.7.3. by Disease Indication
12.7.4. by End-user
12.7.5. by Country/Sub-region
13. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
13.2.1. Troponin Test Kits
13.2.2. CK-MB Test Kits
13.2.3. Myoglobin Test Kits
13.2.4. BNP Test Kit
13.2.5. C-reactive Protein (hsCRP)
13.2.6. Others
13.3. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
13.3.1. Laboratory Testing
13.3.2. Pont-of-care Testing
13.4. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
13.4.1. AngiStent Type Pectoris
13.4.2. Myocardial Infraction
13.4.3. Cardiac Heart Failure
13.4.4. Other
13.5. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
13.5.1. Hospitals
13.5.2. Clinics
13.5.3. Diagnostic Laboratory
13.5.4. Others
13.6. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Testing
13.7.3. By Disease Indication
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
14.2.1. Troponin Test Kits
14.2.2. CK-MB Test Kits
14.2.3. Myoglobin Test Kits
14.2.4. BNP Test Kit
14.2.5. C-reactive Protein (hsCRP)
14.2.6. Others
14.3. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
14.3.1. Laboratory Testing
14.3.2. Pont-of-care Testing
14.4. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
14.4.1. AngiStent Type Pectoris
14.4.2. Myocardial Infraction
14.4.3. Cardiac Heart Failure
14.4.4. Other
14.5. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
14.5.1. Hospitals
14.5.2. Clinics
14.5.3. Diagnostic Laboratory
14.5.4. Others
14.6. Latin America Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Testing
14.7.3. By Disease Indication
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Product, 2016–2026
15.2.1. Troponin Test Kits
15.2.2. CK-MB Test Kits
15.2.3. Myoglobin Test Kits
15.2.4. BNP Test Kit
15.2.5. C-reactive Protein (hsCRP)
15.2.6. Others
15.3. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Testing, 2016–2026
15.3.1. Laboratory Testing
15.3.2. Pont-of-care Testing
15.4. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Disease Indication, 2016–2026
15.4.1. AngiStent Type Pectoris
15.4.2. Myocardial Infraction
15.4.3. Cardiac Heart Failure
15.4.4. Other
15.5. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by End-user, 2016–2026
15.5.1. Hospitals
15.5.2. Clinics
15.5.3. Diagnostic Laboratory
15.5.4. Others
15.6. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value Forecast, by Country/Sub-region, 2016–2026
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Testing
15.7.3. By Disease Indication
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (by Tier and Size of companies)
16.2. Market Share Analysis by Company (2017)
16.3. Competitive Business Strategies
16.4. Company Profiles
16.4.1. Abbott Laboratories Ltd.
16.4.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.1.2. Business Overview
16.4.1.3. Product Portfolio
16.4.1.4. Financial Overview
16.4.1.5. SWOT Analysis
16.4.2. Hoffmann-La Roche AG
16.4.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.2.2. Business Overview
16.4.2.3. Product Portfolio
16.4.2.4. Financial Overview
16.4.2.5. SWOT Analysis
16.4.3. Bio-Rad Laboratories
16.4.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.3.2. Business Overview
16.4.3.3. Product Portfolio
16.4.3.4. Financial Overview
16.4.3.5. SWOT Analysis
16.4.4. Danaher Corporation
16.4.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.4.2. Business Overview
16.4.4.3. Product Portfolio
16.4.4.4. Financial Overview
16.4.4.5. SWOT Analysis
16.4.5. Seimens Healthineers
16.4.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.5.2. Business Overview
16.4.5.3. Product Portfolio
16.4.5.4. Financial Overview
16.4.5.5. SWOT Analysis
16.4.6. Thermofisher Scientific
16.4.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.6.2. Business Overview
16.4.6.3. Product Portfolio
16.4.6.4. Financial Overview
16.4.6.5. SWOT Analysis
16.4.7. bioMérieux
16.4.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.7.2. Business Overview
16.4.7.3. Product Portfolio
16.4.7.4. Financial Overview
16.4.7.5. SWOT Analysis
16.4.8. Ortho Clinical Diagnostics
16.4.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)
16.4.8.2. Business Overview
16.4.8.3. Product Portfolio
16.4.8.4. Financial Overview
16.4.8.5. SWOT Analysis
Table 01: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 03: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 04: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 05: Global Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 07: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 08: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 09: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: North America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 11: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 12: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 13: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 14: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Europe Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 16: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 17: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 18: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 19: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 20: Asia Pacific Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 21: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 22: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 23: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 24: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 25: Latin America Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 26: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Product, 2016–2026
Table 27: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Disease Indication, 2016–2026
Table 28: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Testing, 2016–2026
Table 29: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Middle East & Africa Cardiac Biomarker Diagnostic Kits Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026